• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

liquidation

closed shuttered shut down closed
Biotech

Hookipa, having sold off vaccines to Gilead, opts to wind down

With its Poolbeg merger plans having bitten the dust and key assets sold to Gilead, Hookipa Pharma has decided it’s time to shut up shop completely.
James Waldron Jul 21, 2025 3:15am
door exit shut close end walk away

Alis wants to free capital 'trapped' at struggling biotechs

Apr 18, 2025 9:45am
brain art

Struggling Relmada pays $3M for Tourette's asset from Asarina

Feb 7, 2025 11:00am
end of the road road block shut down closed blocked

Asarina to close after efforts to partner Tourette's drug fail

Jul 24, 2024 10:32am
sale for sale sell

SQZ opts for liquidation, $11.8M asset fire sale to Stemcell

Mar 1, 2024 10:20am
unravel break rope tie fray fall apart thread string

The unraveling of EQRx's low-cost drug dream

Oct 5, 2023 10:47am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings